Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prevalence of VKORC1 1639 G>A and CYP2C923 genotypes in patients that requiring anticoagulant therapy in Turkish population.

Molecular biology reports - 1 Dec 2012

Silan Coskun, Dogan Omer Tamer, Silan Fatma, Kukulguven Fatma Mutlu, Asgun Halil Fatih, Ozdemir Semra, Uludag Ahmet, Atik Sinem, Gungor Buket, Akdur Seçil, Aksulu Hakki Engin, Ozdemir Oztürk

Abstract excerpt

The aim was to investigate the prevalence of VKORC1 and CYP2C9 genotypes in patients requiring anticoagulant therapy in two different region's populations of Turkey. The recent cohort included 292 patients that needed anticoagulant therapy, and who had a history of deep vein thrombosis and/or pulmonary artery thromboembolism. Genomic DNA was isolated from peripheral blood samples and the StripAssay reverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Follow-Up Studies

Share to Mixed Function Oxygenases

Share to Prevalence

Share to Turkey

Share to Vitamin K Epoxide Reductases

Source

Identifiers

PMID: 23065265
DOI: 10.1007/s11033-012-2004-2

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.PMID 23065265Read ↗

Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.Semantic proximity Read ↗

Frequencies of VKORC1 -1639 G>A, CYP2C9*2 and CYP2C9*3 genetic variants in the Northern Indian population.Semantic proximity Read ↗

Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran.Semantic proximity Read ↗

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.Semantic proximity Read ↗

The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk.Semantic proximity Read ↗

Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.Semantic proximity Read ↗

VKORC1 and CYP2C9 genotype distribution in Asian countries.Semantic proximity Read ↗

FREQUENCY OF VKORC1 AND CYP2C9 GENES POLYMORPHISM IN ABKHAZIAN POPULATION.Semantic proximity Read ↗

Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in northern Thailand.Semantic proximity Read ↗

Frequency Distribution of CYP2C9 and VKORC1 Mutations among Bulgarian Patients and their Importance for Anticoagulant Therapy.Semantic proximity Read ↗

[FREQUENCY OF POLYMORPHISM OF VKORC1 AND CYP2C9 GENES IN TWO REGIONS OF GEORGIA].Semantic proximity Read ↗

Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.